Magic mushroom therapy offers hope to the dying
NCT ID NCT04950608
First seen Oct 31, 2025 · Last updated Apr 28, 2026 · Updated 25 times
Summary
This small pilot study looked at whether psilocybin (the active ingredient in magic mushrooms) combined with talk therapy could help reduce demoralization—deep feelings of hopelessness—in 15 hospice patients with terminal illnesses. The main goal was to see if the approach was feasible and acceptable, not to prove it works. Results focused on enrollment rates and patient feedback, with quality of life measured as a secondary outcome.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PSILOCYBIN are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Care Dimensions
Danvers, Massachusetts, 01923, United States
Conditions
Explore the condition pages connected to this study.